At2g01130 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At2g01130 antibody; F10A8.1 antibody; F23H14DExH-box ATP-dependent RNA helicase DExH5 antibody; mitochondrial antibody; EC 3.6.4.13 antibody
Target Names
At2g01130
Uniprot No.

Target Background

Database Links

KEGG: ath:AT2G01130

STRING: 3702.AT2G01130.1

UniGene: At.42514

Protein Families
DExH box helicase family
Subcellular Location
Mitochondrion.

Q&A

Basic Research Questions

How to validate specificity of At2g01130 antibodies in Arabidopsis protein extracts?

Perform orthogonal validation using:

  • Western blotting: Compare wild-type vs. T-DNA insertion mutants (e.g., SALK_012345) to confirm absence of signal in mutants

  • Immunofluorescence: Validate subcellular localization against GFP-tagged At2g01130 lines

  • Peptide competition assays: Pre-incubate antibody with immunogen peptide (e.g., residues 50-75 of At2g01130) to confirm signal loss

What experimental controls are essential when studying At2g01130 protein interactions?

Control TypeImplementationPurpose
Negative GeneticAt2g01130 knockout mutantsConfirm antibody specificity
Positive TechnicalRecombinant At2g01130 proteinVerify detection capability
Cross-ReactivityHeterologous expression in NicotianaTest species specificity

Which detection methods optimize signal-to-noise ratio for low-abundance targets?

  • Combine tyramide signal amplification with standard immunofluorescence

  • Use chemiluminescent substrates with extended exposure times (30min-2hr) in western blotting

  • Implement tandem affinity purification for co-IP experiments

Advanced Research Challenges

How to resolve contradictory data in At2g01130 protein abundance studies?

Conflict ScenarioResolution Strategy
Tissue-specific vs. whole-plant quantificationLaser capture microdissection + nanoLC-MS/MS
Developmental stage disparitiesSynchronized growth chambers with time-course sampling
Antibody vs. RNA-seq expression mismatchParallel SRM/MRM mass spectrometry validation

What statistical approaches address heterogeneity in antibody-based quantification?

  • Apply mixed-effects modeling for batch variations:

    Yij=β0+β1Xij+ui+εijY_{ij} = β_0 + β_1X_{ij} + u_i + ε_{ij}

    Where uiu_i represents batch-specific random effects

  • Implement quantile normalization across technical replicates

How to design longitudinal studies tracking At2g01130 dynamics?

  • Use mathematical modeling of antibody turnover:

    d[Ab]dt=kprodr[Ab]\frac{d[Ab]}{dt} = k_{prod} - r[Ab]

    Where kprodk_{prod} = production rate, rr = clearance rate

  • Sample at critical transitions:

    • Circadian phases (ZT0, ZT8, ZT16)

    • Stress response timepoints (0, 15, 60min post-treatment)

Methodological Optimization

Which multi-omics integration strategies enhance functional characterization?

  • Parallel antibody arrays: 40-plex Luminex assays for pathway analysis

  • Spatial transcriptomics correlation: MERFISH + antibody staining co-localization

  • CRISPR-Cas9 perturbation screens: Link antibody signals to genetic interactome

How to validate antibody performance across Arabidopsis ecotypes?

EcotypeSNP FrequencyValidation Approach
Col-0ReferenceBaseline validation
Cvi-02.3 SNPs/kbEpitope region sequencing
Sha1.8 SNPs/kbRecombinant protein expression

What computational tools analyze antibody binding thermodynamics?

  • RosettaAntibody: Predicts binding energy landscapes (ΔGbindΔG_{bind})

  • HADDOCK: Models antibody-antigen docking using CSP data

  • ABodyBuilder2: Generates 3D structural ensembles from NGS data

Critical Analysis Framework

How to assess clinical relevance of plant antibody research?

  • Apply translational scoring matrix:

CriterionWeightAssessment Method
Structural conservation0.3Phyre2 homology modeling
Pathway essentiality0.4Essential gene databases
Disease association0.3OMIM/ClinVar cross-referencing

What validation thresholds ensure reproducibility?

  • Establish laboratory-specific validation criteria:

    • ≥90% signal reduction in knockout controls

    • ≤15% CV across experimental batches

    • R² ≥ 0.85 in antibody-mass spectrometry correlations

How to troubleshoot nonspecific bands in western blots?

  • 2D gel electrophoresis: Separate proteins by pI and MW

  • Immunodepletion: Pre-clear extracts with protein A/G beads

  • Cross-validation: Compare multiple antibody clones (e.g., CSB-PA564628 vs. Agrisera AS12-1852)

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.